Future directions of neoadjuvant therapy in pancreatic cancer

Neoadjuvant therapy with conventional chemotherapies have visibly improved the prognosis of locally advanced pancreatic cancer (PCa). However, molecular targeted therapies that have provided durable responses in other tumor entities, have not yet found access into neoadjuvant therapy of PCa. In fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Mota Reyes, Carmen, Yurteri, Ümmügülsüm, Friess, Helmut, Ekin Demir, Ihsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458337/
https://www.ncbi.nlm.nih.gov/pubmed/32923514
http://dx.doi.org/10.18632/oncoscience.506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458337/
https://www.ncbi.nlm.nih.gov/pubmed/32923514
http://dx.doi.org/10.18632/oncoscience.506

Ejemplares similares